Filing Details
- Accession Number:
- 0001104659-21-153088
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-23 16:01:46
- Reporting Period:
- 2021-12-21
- Accepted Time:
- 2021-12-23 16:01:46
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1410939 | Iveric Bio Inc. | ISEE | Pharmaceutical Preparations (2834) | 208185347 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1703623 | Francis David Carroll | C/O Iveric Bio, Inc. 5 Penn Plaza, Suite 2372 New York NY 10001 | Svp, Cfo And Treasurer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-12-21 | 56,207 | $15.98 | 48,823 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sale reported on this form was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 19, 2021.
- The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $15.50 to $16.15 per share on December 21, 2021. The Reporting Person undertakes to provide upon request by the staff of the Securities Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range.